arrow
B

Belinda Lee

forensic medicine division
H指数:26
被引数:4,013

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quantifying setup uncertainty between computed tomography guidance and magnetic resonance guidance in intramuscular metastases radiotherapy

定量评估肌肉内转移瘤放射治疗中计算机断层扫描引导与磁共振引导之间的设置不确定性

2026-04-190
OAAI
Endoscopic ultrasound molecular evaluation of pancreatic cancer trial to profile molecular landscape of inoperable pancreatic ductal adenocarcinoma

内镜超声分子评估胰腺癌试验以描绘不可手术胰腺导管腺癌的分子景观

2026-01-130
OA
Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry
2025-10-310
PRE
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial

循环肿瘤DNA指导的辅助治疗在局部晚期结肠癌中的应用:随机II/III期DYNAMIC-III试验

2025-10-200
PRE
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer

探索一线EGFR抑制剂使用、西妥昔单抗与帕尼单抗在左侧RAS野生型转移性结直肠癌患者中的真实世界结局

2025-04-300
PRE
Initial Assessment of Resectability of Colorectal Cancer Liver Metastases Versus Clinical Outcome

结直肠癌肝转移可切除性与临床结局的初步评估

2025-03-010
PRE
A multi-centre analysis of metastatic colorectal cancer diagnosed under the age of 35: A molecularly distinct group?

35岁以下诊断的转移性结直肠癌的多中心分析:一个分子上独特的群体?

2024-12-010
PRE
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry
2022-10-0115
PRE
Clinical Implementation and Initial Experience With a 1.5 Tesla MR-Linac for MR-Guided Radiation Therapy for Gynecologic Cancer: An R-IDEAL Stage 1 and 2a First in Humans Feasibility Study of New Technology Implementation
2022-07-014
OAAI